Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Kadmon Holdings Inc. (KDMN)

9.5   0 (0%) 01-25 23:20
Open: 9.49 Pre. Close: 9.5
High: 9.495 Low: 9.48
Volume: 10,424,582 Market Cap: 1,696M
Kadmon Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecules and biologics primarily for the treatment of inflammatory and fibrotic diseases. Its lead product candidates include KD025, an orally administered selective inhibitor of the rho-associated coiled-coil kinase 2, which is in Phase II clinical trial for the treatment of chronic graft-versus-host and fibrotic diseases; KD045, an oral inhibitor of ROCK for the treatment of fibrotic diseases; and KD033, an anti-PD-L1/IL-15 fusion protein for the treatment of cancer. The company also engages in developing Tesevatinib to treat autosomal dominant polycystic kidney disease; ribavirin, a nucleoside Inhibitor to treat hepatitis; and CLOVIQUE, a trientine hydrochloride capsules for the treatment of Wilson's disease. Kadmon Holdings, Inc. has strategic collaborations and license agreements with Nano Terra, Inc. and Dyax Corp. The company was founded in 2010 and is headquartered in New York, New York.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 9.522 - 9.569 9.569 - 9.607
Low: 9.347 - 9.413 9.413 - 9.465
Close: 9.409 - 9.507 9.507 - 9.587

Technical analysis

as of: 2022-01-25 4:25:13 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 11.10     One year: 12.96
Support: Support1: 9.49    Support2: 9.48
Resistance: Resistance1: 9.50    Resistance2: 11.10
Pivot: 9.50
Moving Average: MA(5): 9.50     MA(20): 9.50
MA(100): 8.43     MA(250): 5.89
MACD: MACD(12,26): 0.03     Signal(9): 0.04
Stochastic oscillator: %K(14,3): 100.00     %D(3): 100.00
RSI: RSI(14): 72.90
52-week: High: 9.50  Low: 3.45  Change(%): 131.7
Average Vol(K): 3-Month: 9638  10-Days: 10425

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
KDMN has closed Bollinger Bands are 100% narrower than normal. The narrow width of the bands suggests low volatility as compared to Kadmon Holdings Inc.'s normal range. The bands have been in this narrow range for 35 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 09 Nov 2021
Sanofi completes acquisition of Kadmon - Yahoo Finance

Tue, 19 Oct 2021
First Week of June 2022 Options Trading For Kadmon Holdings (KDMN) - Nasdaq

Thu, 07 Oct 2021
SHAREHOLDER ALERT: WeissLaw LLP Reminds XLRN, JMP, ECHO, and KDMN Shareholders About Its Ongoing Investigations - Yahoo Finance

Fri, 10 Sep 2021
KADMON HOLDINGS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kadmon Holdings, Inc. - KDMN - Business Wire

Wed, 08 Sep 2021
Should You Hold Kadmon Holdings Inc (KDMN) Stock Wednesday Morning? - InvestorsObserver

Wed, 08 Sep 2021
Why Kadmon Holdings Stock Is Rocketing Higher Today - Motley Fool

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M)
Shares Float (M)
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio 1.#J
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.